These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6132559)

  • 1. A comparison of patients who refuse and consent to neuroleptic treatment.
    Marder SR; Mebane A; Chien CP; Winslade WJ; Swann E; Van Putten T
    Am J Psychiatry; 1983 Apr; 140(4):470-2. PubMed ID: 6132559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotic patients' understanding of informed consent.
    Irwin M; Lovitz A; Marder SR; Mintz J; Winslade WJ; Van Putten T; Mills MJ
    Am J Psychiatry; 1985 Nov; 142(11):1351-4. PubMed ID: 2865904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of hospitalized psychotic patients who refuse antipsychotic drug therapy.
    Zito JM; Routt WW; Mitchell JE; Roerig JL
    Am J Psychiatry; 1985 Jul; 142(7):822-6. PubMed ID: 2861754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of psychopathology on the ability of schizophrenic patients to give informed consent.
    Schachter D; Kleinman I; Prendergast P; Remington G; Schertzer S
    J Nerv Ment Dis; 1994 Jun; 182(6):360-2. PubMed ID: 7911156
    [No Abstract]   [Full Text] [Related]  

  • 5. Involuntary patients' right to refuse medication: impact of the Riese decision on a California inpatient unit.
    Binder RL; McNiel DE
    Bull Am Acad Psychiatry Law; 1991; 19(4):351-7. PubMed ID: 1686192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilemma of denial in the assessment of competency to refuse treatment.
    Roth LH; Appelbaum PS; Sallee R; Reynolds CF; Huber G
    Am J Psychiatry; 1982 Jul; 139(7):910-3. PubMed ID: 6124132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent and tardive dyskinesia.
    Kleinman I; Schachter D; Koritar E
    Am J Psychiatry; 1989 Jul; 146(7):902-4. PubMed ID: 2568093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of patients' refusal of antipsychotic medication under a physician discretion review procedure.
    Kasper JA; Hoge SK; Feucht-Haviar T; Cortina J; Cohen B
    Am J Psychiatry; 1997 Apr; 154(4):483-9. PubMed ID: 9090334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR; Roth LH; Cornes CL
    Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
    [No Abstract]   [Full Text] [Related]  

  • 11. Informed consent: assessment of comprehension.
    Wirshing DA; Wirshing WC; Marder SR; Liberman RP; Mintz J
    Am J Psychiatry; 1998 Nov; 155(11):1508-11. PubMed ID: 9812110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guardianship and the right to refuse treatment: a critique of the Roe case.
    Mills MJ; Gutheil TG
    Bull Am Acad Psychiatry Law; 1981; 9(4):239-46. PubMed ID: 6124289
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients' competency to give informed consent to medication.
    Beck JC; Staffin RD
    Hosp Community Psychiatry; 1986 Apr; 37(4):400-2. PubMed ID: 2870979
    [No Abstract]   [Full Text] [Related]  

  • 14. Documenting informed consent for treatment with neuroleptics: an alternative to the consent form.
    Munetz MR; Peterson GA
    Psychiatr Serv; 1996 Mar; 47(3):302-3. PubMed ID: 8820557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competence to give informed consent for medical procedures.
    Weinstock R; Copelan R; Bagheri A
    Bull Am Acad Psychiatry Law; 1984; 12(2):117-25. PubMed ID: 6743844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consent to treatment: loophole in the Ontario Mental Health Act.
    Jaychuk G; Manchanda R; Galbraith DA
    Can J Psychiatry; 1991 Oct; 36(8):594-6. PubMed ID: 1742714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patients' perspective on the quality of informed consent into psychopharmacological treatment in schizophrenia and depression].
    Schildmann J; Bauer A; Tilmann A; Vollmann J
    Fortschr Neurol Psychiatr; 2003 May; 71(5):265-70. PubMed ID: 12740758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining competency to assent to neuroleptic drug treatment.
    Beck JC
    Hosp Community Psychiatry; 1988 Oct; 39(10):1106-8. PubMed ID: 2906625
    [No Abstract]   [Full Text] [Related]  

  • 20. Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.
    Brabbins C; Butler J; Bentall R
    Br J Psychiatry; 1996 May; 168(5):540-4. PubMed ID: 8733791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.